OBJECTIVE: Patient antiretroviral (ARV) therapy knowledge is essential for regimen adherence, successful therapeutic response, and minimization of resistance evolution. Moreover, a complete and accurate patient ARV history is needed to construct efficacious and tolerable future regimens. In this study we assessed the ability of HIV-infected patients receiving care in a university infectious diseases clinic to accurately recall current and past ARVs. METHODS: A convenience sample (n = 205) of UNC HIV Clinical Cohort participants (n = 1840) completed a comprehensive in-person interview. Patients were asked about current and ever ARV use and were provided proprietary and generic ARV names and photographs. Self-reported sensitivity for current and ever ARV use (proportion that correctly identified all recorded ARVs), was calculated using the medical record as the gold standard. RESULTS: One hundred and eighty-five patients had received ARVs at some point after enrollment in the cohort study (ever users). For current ARV use (n = 138), self-reported sensitivity was 63% (95% CI: 54-71). For ever use (n = 185), sensitivity was 18% (95% CI: 13-24). CONCLUSION: Self-reported cumulative ARV use is not accurate. Since HIV-infected patients are prescribed a number of medications over their treatment course, it is necessary to develop new medication reconciliation techniques that are not dependent on patient memory or knowledge in order to improve patient outcomes.
OBJECTIVE: Patient antiretroviral (ARV) therapy knowledge is essential for regimen adherence, successful therapeutic response, and minimization of resistance evolution. Moreover, a complete and accurate patient ARV history is needed to construct efficacious and tolerable future regimens. In this study we assessed the ability of HIV-infected patients receiving care in a university infectious diseases clinic to accurately recall current and past ARVs. METHODS: A convenience sample (n = 205) of UNC HIV Clinical Cohort participants (n = 1840) completed a comprehensive in-person interview. Patients were asked about current and ever ARV use and were provided proprietary and generic ARV names and photographs. Self-reported sensitivity for current and ever ARV use (proportion that correctly identified all recorded ARVs), was calculated using the medical record as the gold standard. RESULTS: One hundred and eighty-five patients had received ARVs at some point after enrollment in the cohort study (ever users). For current ARV use (n = 138), self-reported sensitivity was 63% (95% CI: 54-71). For ever use (n = 185), sensitivity was 18% (95% CI: 13-24). CONCLUSION: Self-reported cumulative ARV use is not accurate. Since HIV-infected patients are prescribed a number of medications over their treatment course, it is necessary to develop new medication reconciliation techniques that are not dependent on patient memory or knowledge in order to improve patient outcomes.
Authors: Michael S Wolf; Terry C Davis; Chandra Y Osborn; Silvia Skripkauskas; Charles L Bennett; Gregory Makoul Journal: Patient Educ Couns Date: 2006-11-21
Authors: Evan Wood; Thomas Kerr; Robert S Hogg; Ruth Zhang; Mark W Tyndall; Julio S G Montaner Journal: J Acquir Immune Defic Syndr Date: 2006-04-01 Impact factor: 3.731
Authors: Ray Y Chen; Andrew O Westfall; Michael J Mugavero; Gretchen A Cloud; James L Raper; Ashlee G Chatham; Edward P Acosta; Kelly H Taylor; Jerome Carter; Michael S Saag Journal: Clin Infect Dis Date: 2003-08-13 Impact factor: 9.079
Authors: José Valdez Madruga; Pedro Cahn; Beatriz Grinsztejn; Richard Haubrich; Jacob Lalezari; Anthony Mills; Gilles Pialoux; Timothy Wilkin; Monika Peeters; Johan Vingerhoets; Goedele de Smedt; Lorant Leopold; Roberta Trefiglio; Brian Woodfall Journal: Lancet Date: 2007-07-07 Impact factor: 79.321
Authors: Rupali Kotwal Doshi; Nicholas S Vogenthaler; Sarah Lewis; Allan Rodriguez; Lisa Metsch; Carlos del Rio Journal: AIDS Res Hum Retroviruses Date: 2012-03-02 Impact factor: 2.205
Authors: Babafemi Taiwo; Lu Zheng; Sebastien Gallien; Roy M Matining; Daniel R Kuritzkes; Cara C Wilson; Baiba I Berzins; Edward P Acosta; Barbara Bastow; Peter S Kim; Joseph J Eron Journal: AIDS Date: 2011-11-13 Impact factor: 4.177
Authors: Christine U Oramasionwu; Jim M Koeller; Kenneth A Lawson; Carolyn M Brown; Gene D Morse; Christopher R Frei Journal: Med Care Date: 2012-11 Impact factor: 2.983
Authors: S Esser; A Haberl; F Mulcahy; J Gölz; A Lazzarin; E Teofilo; J Vera; A Körber; S Staszewski Journal: Eur J Med Res Date: 2011-10-10 Impact factor: 2.175
Authors: Ann M Dennis; Jennifer B Wheeler; Erik Valera; Lisa Hightow-Weidman; Sonia Napravnik; Heidi Swygard; Clare Barrington; Joseph J Eron Journal: AIDS Care Date: 2013-02-05